Insider screener

Period: 12 months Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,258 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,258 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,258 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,258 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,258 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,258 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,258 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
21 Jan 2026
Ned S Holmes Director · indirect
Sold on a plan 4×
$44.57K 600 at 74.29
1.4%
Planned (10b5-1)
21 Jan 2026
J. Jefferson Smith Chief Research Officer
Sold on a plan
$41.11K 10,200 at 4.03
8.5%
Planned (10b5-1)
21 Jan 2026
Paul V Walsh Jr Director
Sold on a plan
$39.13K 500 at 78.25
1.9%
Planned (10b5-1)
21 Jan 2026
Ned S Holmes Director
Sold on a plan 2×
$37.14K 500 at 74.29
0.6%
Planned (10b5-1)
21 Jan 2026
Dario Scimeca General Counsel and Secretary
Sold on a plan
$35.68K 8,854 at 4.03
16.5%
Planned (10b5-1)
21 Jan 2026
Edward J. Lehner President & CEO
Sold on a plan
$30.01K 1,000 at 30.01
0.2%
Planned (10b5-1)
21 Jan 2026
Brian Cree President
Sold on a plan
$28.36K 1,440 at 19.69
0.3%
Planned (10b5-1)
21 Jan 2026
John O Agwunobi Director
Sold on a plan
$26.03K 146 at 178.31
1.6%
Planned (10b5-1)
21 Jan 2026
Peter Platzer Executive Chairman
Sold on a plan
$21.79K 1,801 at 12.10
0.1%
Planned (10b5-1)
21 Jan 2026
Sold on a plan
$20.50K 25,000 at 0.82
14.3%
Planned (10b5-1)
21 Jan 2026
Charles Peter Kirol Chief Operating Officer
Sold on a plan
$19.90K 3,399 at 5.85
4.2%
Planned (10b5-1)
21 Jan 2026
Theresa Condor Chief Executive Officer
Sold on a plan
$14.53K 1,201 at 12.10
0.1%
Planned (10b5-1)
21 Jan 2026
David Sherry Chief Financial Officer
Sold on a plan 4×
$12.80K 145 at 88.26
0.0%
Planned (10b5-1)
21 Jan 2026
Lei Wu Chief Executive Officer · indirect
Sold on a plan
$8.45K 210 at 40.26
0.0%
Planned (10b5-1)
21 Jan 2026
Randall Moreadith Chief Scientific Officer
Sold on a plan
$6.00K 2,000 at 3.00
100%
Sold half or more
21 Jan 2026
John Walter Hanna JR President and CEO
Sold on a plan
$4.20K 200 at 21.00
0.0%
Planned (10b5-1)
20 Jan 2026
Frank Slootman Director
Sold on a plan 5×
$41.35M 200,000 at 206.77
79.9%
Sold half or more
20 Jan 2026
Bought on a plan 2×
$21.02M 310,000 at 67.80
0.6%
Bought on a plan
20 Jan 2026
Steven Leonard Chapman CEO and President
Sold on a plan
$16.89M 71,932 at 234.74
24.9%
Planned (10b5-1)
20 Jan 2026
Michael Benkowitz President and COO · indirect
Sold on a plan 28×
$10.45M 22,500 at 464.66
100%
Sold half or more
20 Jan 2026
Brannin McBee Chief Development Officer
Sold on a plan 5×
$9.80M 102,835 at 95.29
29.3%
Planned (10b5-1)
20 Jan 2026
Sanjit Biswas Chief Executve Officer · indirect
Sold on a plan 6×
$8.56M 263,900 at 32.43
77.0%
Sold half or more
20 Jan 2026
John Bicket See Remarks · indirect
Sold on a plan 6×
$8.56M 263,900 at 32.43
77.0%
Sold half or more
20 Jan 2026
Jennifer L. Wong Chief Operating Officer
Sold on a plan 9×
$6.13M 27,159 at 225.73
2.3%
Planned (10b5-1)
20 Jan 2026
Brannin McBee Chief Development Officer · indirect
Sold on a plan 35×
$6.08M 63,835 at 95.29
100%
Sold half or more
20 Jan 2026
Michael Burkes Brophy Chief Financial Officer
Sold on a plan
$5.62M 23,948 at 234.74
19.4%
Planned (10b5-1)
20 Jan 2026
Solomon Moshkevich President, Clinicaldiagnostics
Sold on a plan
$5.45M 23,205 at 234.74
13.8%
Planned (10b5-1)
20 Jan 2026
Daniel Rabinowitz Sec. and Chief Legal Officer
Sold on a plan
$4.51M 19,234 at 234.74
7.8%
Planned (10b5-1)
20 Jan 2026
John Fesko President, Chief Bus. Officer
Sold on a plan
$4.18M 17,806 at 234.74
9.1%
Planned (10b5-1)
20 Jan 2026
Andrew Bialecki Co-Chief Executive Officer
Sold on a plan 2×
$4.06M 167,926 at 24.16
100%
Sold half or more
20 Jan 2026
Kenneth Duda President and CTO
Sold on a plan 4×
$3.85M 30,000 at 128.43
69.8%
Sold half or more
20 Jan 2026
Ishbia Mat President and CEO · indirect
Sold on a plan
$3.68M 632,874 at 5.82
9.6%
Planned (10b5-1)
20 Jan 2026
Kenneth Duda President and CTO · indirect
Sold on a plan 8×
$3.34M 26,000 at 128.43
4.7%
Planned (10b5-1)
20 Jan 2026
Prabir Adarkar President and COO
Sold on a plan 7×
$3.07M 15,000 at 204.59
1.7%
Planned (10b5-1)
20 Jan 2026
Terrance P. Coyne EVP & CFO · indirect
Sold on a plan 2×
$2.74M 69,582 at 39.35
65.9%
Sold half or more
20 Jan 2026
Jennifer L. Wong Chief Operating Officer · indirect
Sold on a plan 9×
$2.71M 12,008 at 225.73
19.3%
Planned (10b5-1)
20 Jan 2026
Brian Halligan Director
Sold on a plan
$2.58M 8,500 at 303.38
1.7%
Planned (10b5-1)
20 Jan 2026
Mayur Ian Somaiya Chief Financial Officer
Sold on a plan 3×
$1.92M 60,216 at 31.96
50.8%
Sold half or more
20 Jan 2026
Mark Pearson President and CEO
Sold on a plan 2×
$1.83M 39,700 at 46.20
5.7%
Planned (10b5-1)
20 Jan 2026
Robert P. Mauch President & CEO
Sold on a plan
$1.81M 5,096 at 354.73
7.1%
Planned (10b5-1)
20 Jan 2026
Thomas J Seifert Chief Financial Officer
Sold on a plan 7×
$1.78M 10,000 at 178.37
6.8%
Planned (10b5-1)
20 Jan 2026
Sold on a plan 2×
$1.73M 21,619 at 79.90
0.3%
Planned (10b5-1)
20 Jan 2026
William Lewis Chair and CEO
Sold on a plan 5×
$1.70M 10,699 at 158.93
3.4%
Planned (10b5-1)
20 Jan 2026
R Stanton Dodge Chief Legal Officer
Sold on a plan 2×
$1.69M 52,777 at 32.01
9.5%
Planned (10b5-1)
20 Jan 2026
Samarth Kulkarni Chief Executive Officer
Sold on a plan 2×
$1.55M 30,000 at 51.75
13.4%
Planned (10b5-1)
20 Jan 2026
Jon A Olson Director
Sold on a plan 10×
$1.39M 15,205 at 91.30
4.2%
Planned (10b5-1)
20 Jan 2026
Sold on a plan
$1.26M 80,520 at 15.67
0.7%
Planned (10b5-1)
20 Jan 2026
III Eric L. (Ric) Sinclair Chief Business Officer
Sold on a plan
$1.21M 40,225 at 30.08
7.8%
Planned (10b5-1)
20 Jan 2026
Barry J. Simon Director
Sold on a plan 2×
$1.09M 151,967 at 7.20
4.7%
Planned (10b5-1)
20 Jan 2026
Gerald L. Morgan CEO, Executive Vice Chairman
Sold on a plan
$980.00K 5,000 at 196.00
5.2%
Planned (10b5-1)
Showing 18,251–18,300 of 23,258. ← Newer Page 366 of 466 Older →